Literature Case Analysis of Kounis Syndrome Induced by Sulbactam and Its Compound Preparations
OBJECTIVE To discuss the occurrence and clinical characteristics of Kounis syndrome(KS)induced by antibacterial drugs containing sulbactam in order to provide references for clinical safety drug use.METHODS The case reports of KS induced by antibacterial drugs containing sulbactam were retrieved from PubMed,Embase,Cochrane Library,CNKI,Wanfang and VIP database from establishment of each database to October 2023.The relevant data were collected and analyzed.RESULTS A total of 11 cases from 11 articles were identified and included in the analysis.There were 7 males(63.6%)and 4 females(36.4%).The patients were aged from 44 to 89 years with an average age of(70.0±13.1)years old,and there were 9 patients aged 70 and above(81.8%).The drugs involved included cefoperazone sulbactam in 5 cases(45.5%),ampicillin sulbactam in 4 cases(36.4%)and piperacillin sulbac-tam in 2 cases(18.2%).The 81.8%of the patients developed acute anaphylaxis within 30 min after treatment and electrocardiogram indicated abnormal ST segment changes.Type Ⅰ,Ⅱ and Ⅲ KS were 8 cases(72.7%),2 cases(18.2%)and 1 case(9.1%),respec-tively.After anti-allergic and anti-myocardial ischemia therapy,10 patients(90.9%)had good prognosis,and 1 patient(9.1%)died of cardiogenic shock.CONCLUSION KS could be induced by a variety of antibacterial drugs containing sulbactam,especially in older patients and mostly within 30 min.KS should be highly suspected once acute anaphylaxis accompanied by abnormal changes in electrocardio-gram Timely withdrawal of medication and targeted treatment according to KS types are the key to improve the prognosis of patients.
sulbactamKounis syndromeacute coronary syndromeliterature case analysis